DoseVault
Metabolic Compound

Exenatide

First-in-class GLP-1 mimetic derived from Gila monster venom; sold as Byetta/Bydureon.

Scientific Overview

Exenatide is a 39-aa synthetic version of exendin-4 from Heloderma suspectum (Gila monster) saliva. It was the first GLP-1 receptor agonist FDA-approved (Byetta, 2005, Amylin/Lilly), with a microsphere weekly formulation Bydureon following in 2012. Largely displaced by liraglutide, semaglutide, and tirzepatide.

Key Research Benefits

  • ✓HbA1c reduction
  • ✓Modest weight loss
  • ✓Long-acting weekly form available

Potential Side Effects

⚠Nausea
⚠Pancreatitis (rare)
⚠Injection-site nodules (Bydureon)

Research Protocols

Common Dosages

T2DM

5-10 mcg BID (Byetta) / 2 mg weekly (Bydureon)
Per formulation

“Within 60 min before meals (Byetta)”

Note: Dosages listed are common research protocols found in peer-reviewed literature and clinical trials. Individual results and requirements may vary significantly in a research context.

Dose Calculator

🧮 Peptide Reconstitution Calculator

mg

Total amount of peptide in the vial.

mL

Volume of water used to mix.

mcg

Draw to this mark

0.2 Units

or 0.00 mL on a U-100 syringe

Concentration:2.50 mg/mL
Peptide per Unit:25.00 mcg/unit
*Always double-check your calculations. This tool is for educational purposes only.

Explore Exenatide

Where to source

Vendors with public COAs that stock this category. Affiliate links are disclosed.

  • Limitless Life Nootropics
    FL-based research-peptide supplier with Janoshik third-party COAs and a public affiliate program at ~20%.
    COA: JanoshikAffiliate disclosed
    View vendor →
  • SwissChems
    60+ peptide catalog with Janoshik COAs; weekly affiliate payouts.
    COA: JanoshikAffiliate disclosed
    View vendor →
  • Amino Club
    EU/US-facing vendor with a 20% first-order / 10% recurring affiliate model.
    COA: Third-partyAffiliate disclosed
    View vendor →

Exenatide by goal

Read Exenatide's profile filtered through specific research goals.

Exenatide for Fat Loss

Molecular Profile

linear
C184H282N50O60S
39 AA Sequence

Quick Reference

Status
Research Compound
Category
Metabolic
Common Dosage
5-10 mcg BID (Byetta) / 2 mg weekly (Bydureon)
Per formulation

Strictly for research purposes. Not for human consumption.

Related tools

Medical Disclaimer

Information provided on DoseVault is for educational and research purposes only. This website does not advocate for the human use of peptides. Peptides are currently sold as research chemicals and are not FDA-approved for human consumption. Always consult a licensed medical professional before considering any protocol.